Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...

A new study published in the journal PNAS by researchers at the Department of Clinical Neuroscience, Karolinska Institutet, ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

UAE doctors warn that summer heat can worsen health issues. People with neurological and cardiovascular diseases are at ...

As climate-related health challenges continue to rise globally, public awareness and inclusive city planning may become as ...

At first, I couldn’t recall a major traumatic event in my past. But when I examined more deeply, I realized that my early ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

AS a parent with a full-time job and a busy social life playing football and seeing friends, Adam Dawar always had somewhere ...

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

The past 30 years have seen a renaissance of the interest of investigators and clinicians for the sympathetic nervous system, a development supported by multiple lines of evidence. First, sympathetic ...